Kevin Smith is recorded as Board Member at Inogen Inc (INGN) since November 10, 2023 and General Counsel and CEO at Inogen Inc (INGN). Inogen Inc reported in an 8-K filed November 13, 2023 that Kevin Smith was appointed President and Chief Executive Officer. Inogen Inc reported in an 8-K filed November 13, 2023 that Kevin Smith was appointed Class III director, effective November 10, 2023. Inogen Inc reported in an 8-K filed November 13, 2023 that Kevin Smith was appointed President and Chief Executive Officer, effective November 10, 2023. The proxy statement of Inogen Inc reports total compensation of $1,463,009 for Kevin Smith in fiscal 2025, including a base salary of $432,515. Disclosed compensation is on record for 3 fiscal years. Kevin Smith has spoken on 10 earnings calls and 2 other investor events across 1 company, most recently for Inogen Inc on August 6, 2026. Inogen Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Inogen Inc includes Andrew (“Andy”) P. Reding (CEO and Board Member), Elizabeth Mora (Chairman and Board Member), Jason Richardson (CFO) and 7 others.
“today announced that its Board of Directors has appointed Kevin Smith as Inogen's President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.”
Inogen Inc Form 8-K, filed November 13, 2023
· Read the filing
“In addition, on November 10, 2023, the Board, upon recommendation of the Nominating and Governance Committee of the Board, appointed Mr. Smith to serve as a Class III director of the Company, effective November 10, 2023, with a term expiring at the annual meeting of stockholders to be held in 2026.”
Inogen Inc Form 8-K, filed November 13, 2023
· Read the filing
Kevin Smith on recent calls
“Starting with the Q2 results, Q2 total revenue came in at $95.1 million, growing 3% year-over-year, due to a strong international growth POC demand and contribution from our new products, including Voxy and Aurora Masks.”
“It is a pleasure to welcome you to the 2026 Virtual Annual Meeting of Stockholders. We will begin today with the formal business of the meeting and will follow with a question and answer session.”
“I want to begin by welcoming several new leaders to the Inogen team. These team additions reflect the ambition we have for the next chapter. Jason Richardson joined us as Chief Financial Officer this quarter.”
“And in addition to Jason and looking at the talent development and expansion here in the organization, this, adding the CMO as the VP of sales for the B2B, it's a deliberate realignment to reflect the ambitions that we have as an organization and to accelerate the core priorities that we have, driving top-line growth…”
“I want to use today's call to recap our 2025 success, outline progress on our strategic initiatives, and share why I am confident in delivering improving performance in 2026 and beyond.”
